Table 1.
Population characteristics (n = 116).
Variable | Mean (SD) or n (%) |
---|---|
Age (years) | 58.53 (18.12) |
Sex (% female) | 59 (50.90) |
Morbidity | N of patients with morbidity/Total population |
Myocardial infarction, n (%) | 12 (10.30) |
Heart failure, n (%) | 4 (3.40) |
Peripheral vascular disease, n (%) | 7 (6.00) |
Diabetes mellitus, n (%) | 13 (11.20) |
Cerebrovascular disease, n (%) | 10 (8.60) |
Dementia, n (%) | 5 (4.30) |
Chronic obstructive pulmonary disease n (%) | 9 (7.80) |
Connective tissue disease, n (%) | 13 (11.20) |
Renal disease, n (%) | 6 (5.20) |
Hematologic cancer, n (%) | 1 (0.90) |
Solid tumoral disease, n (%) | 15 (12.90) |
Co-morbidities (sum of diseases) | 0.93 (1.06) |
Frequent medications | |
Antihypertensive drugs | 38 (32.76%) |
Lipid-lowering drugs | 21 (18.10%) |
Anti-diabetic drugs | 6 (5.17%) |
Oxidant lifestyle | |
Dietary oxidant habits (yes) | 57 (49.10) |
Absence of exercise (yes) | 24 (20.70) |
Antioxidative lifestyle * | 51 (44.00) |
Intermediate lifestyle ** | 49 (42.20) |
Prooxidant lifestyle *** | 16 (13.80) |
Hepatic liver fibrosis | |
Quality of life SF-36 categories (0–100) | |
Physical | 78.55 (28.60) |
Physical role | 76.75 (25.38) |
Emotional role | 86.67 (21.58) |
Mental | 69.90 (20.19) |
Social | 78.62 (26.25) |
Vitality | 55.56 (22.58) |
Pain | 64.18 (27.12) |
General | 55.00 (20.19) |
Physical summary | 63.17 (22.68) |
FIB-4 index (points) | 0.65 (0.57) |
* Neither oxidative dietary nor activity habits, ** Either oxidative dietary or activity habits, *** Both dietary and activity oxidative habits. See Appendix A Table A1.